# Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke

> **NCT04434768** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Ever Supreme Bio Technology Co., Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Acute Stroke

## Interventions

- **BIOLOGICAL:** UMSC01

## Key facts

- **NCT ID:** NCT04434768
- **Lead sponsor:** Ever Supreme Bio Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-02
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434768, "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04434768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*